Develop Amivantamab/Lasertinib launch/brand strategy and develop launch readiness programs for launch excellence by driving discussion and aligning views from key stakeholders (China commercial cross functional team, Access/Pricing, MAF, China R& D)

Lead forecasting and financial analysis along business cycle and strategic planning of lung cancer for short to long term growth opportunities and challenges

Collaborate with and influence global partners (commercial and R& D) and regional stakeholders to make sure China market insight and input to be proactively delivered and to maximize China opportunities in the planning and support.

Take lead to make aligned launch strategy and investment with AP and global key stakeholders for brand strategy and launch plan

Develop metrics plan, analyze multichannel activities, track program results and optimize campaigns, following agile methodology (a test-learn-adapt)

Monitor the performance of owned assets against agreed metrics and provide timely reports

Capable to lead direct report (2 product managers) and grow people and capabilityExpertise and rich hands on experiences in lung cancer commercial & marketing in strategy development and execution (minimum 3 yrs of hands on experiences)

Experiences of partnering with AP regional/global key stakeholders to communicate, drive alignment and develop agenda to make influence.

Proven track record in developing business planning and launching new products as well as developing business models

Experiences of portfolio management and pipeline management from end to end perspectives (early pipeline to launch/in line products)

Strong and proven leadership and people development experience and skills

Strong communication skills and stakeholder management capabilities including multi-national cross functional team and global team

Ability to work with a broad base of internal and external partners

Fluent in English

Innovative